Fecal Occult Blood Testing Tied to Reduction in Colorectal Cancer Mortality

Routine screening with fecal occult blood testing (FOBT) is associated with a decrease in colorectal cancer (CRC) mortality, according to a study published online Feb. 27 in JAMA Network Open.

Johannes Blom, M.D., Ph.D., from the Karolinska Institutet in Stockholm, and colleagues evaluated cancer-specific mortality associated with early versus late or no invitation for routine CRC screening using FOBT. The analysis included 203,670 individuals invited early and 175,778 invited late or not at all (control group).

Source: Advances and More licensed by HealthDay